Header Logo

Interfering with the IFN-?/CXCL10 pathway to develop new targeted treatments for vitiligo.

Rashighi M, Harris JE. Interfering with the IFN-?/CXCL10 pathway to develop new targeted treatments for vitiligo. Ann Transl Med. 2015 Dec; 3(21):343.

View in: PubMed